Sinusoidal obstruction syndrome diagnostic study of choice: Difference between revisions
| Line 14: | Line 14: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |Baltimore Criteria | ||
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |Seattle criteria | ||
|- | |- | ||
| | | | ||
* Direct measurement | * Direct measurement | ||
| | | | ||
* < 200 mg/dl | * < 200 mg/dl | ||
|- | |- | ||
| | | | ||
* [[Blood]] [[pH]] | * [[Blood]] [[pH]] | ||
| | | | ||
* 7.35-7.45 | * 7.35-7.45 | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" | | ||
* (Na<sup>+</sup>) – (Cl<sup>–</sup> + HCO3<sup>–</sup>) | * (Na<sup>+</sup>) – (Cl<sup>–</sup> + HCO3<sup>–</sup>) | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" | | ||
* 7 to 13 (mEq/L) | * 7 to 13 (mEq/L) | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" | | ||
* 2([[Sodium|Na]] + [[Potassium|K]]) + ([[glucose]]/18) + ([[blood]] [[urea]] [[nitrogen]]/2.8) | * 2([[Sodium|Na]] + [[Potassium|K]]) + ([[glucose]]/18) + ([[blood]] [[urea]] [[nitrogen]]/2.8) | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" | | ||
* 285 to 295 mOsm/kg (285 to 295 mmol/kg) of water | * 285 to 295 mOsm/kg (285 to 295 mmol/kg) of water | ||
|- | |- | ||
| | | | ||
* Direct measurement | * Direct measurement | ||
| | | | ||
* Negative | * Negative | ||
|- | |- | ||
| | | | ||
* Direct measurement | * Direct measurement | ||
| | | | ||
* Negative | * Negative | ||
|- | |- | ||
| | | | ||
* Direct measurement | * Direct measurement | ||
| | | | ||
* 23 - 29 mEq/L | * 23 - 29 mEq/L | ||
|- | |- | ||
| | | | ||
* N/A | * N/A | ||
| Line 81: | Line 57: | ||
* [[BUN]]: 7-20 mg/dl | * [[BUN]]: 7-20 mg/dl | ||
* [[Creatinine]] levels: 0.8-1.2mg/dl | * [[Creatinine]] levels: 0.8-1.2mg/dl | ||
|} | |} | ||
Revision as of 19:59, 2 February 2018
|
Sinusoidal obstruction syndrome Microchapters |
|
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sinusoidal obstruction syndrome diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome diagnostic study of choice |
|
FDA on Sinusoidal obstruction syndrome diagnostic study of choice |
|
CDC on Sinusoidal obstruction syndrome diagnostic study of choice |
|
Sinusoidal obstruction syndrome diagnostic study of choice in the news |
|
Blogs on Sinusoidal obstruction syndrome diagnostic study of choice |
|
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
|
Risk calculators and risk factors for Sinusoidal obstruction syndrome diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Diagnostic Criteria
The diagnosis of sinusoidal obstruction syndrome should be considered in any patient who has undergone hematopoietic cell transplant and develops liver dysfunction.
- The two established criteria for the clinical diagnosis of sinusoidal obstruction syndrome are:
| Baltimore Criteria | Seattle criteria |
|---|---|
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|